bluebird bio (BLUE) PT Lowered to $50 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on bluebird bio (NASDAQ: BLUE) to $50.00 (from $68.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Macquarie Upgrades Merdeka Gold Resources (EMAS:IJ) to Neutral
- Britannia Industries Ltd (BRIT:IN) PT Raised to INR5,100 at Macquarie
- Kasikornbank PCL (KBANK:TB) (KPCPY) PT Raised to THB280 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
